SUMATRIPTAN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 19 adverse event reports in the FDA FAERS database where SUMATRIPTAN was used for Psoriasis.
Most Reported Side Effects for SUMATRIPTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 2,941 | 16.9% | 4 | 158 |
| Product physical issue | 2,349 | 13.5% | 0 | 10 |
| Application site erythema | 1,875 | 10.8% | 0 | 5 |
| Drug dose omission | 1,711 | 9.8% | 0 | 12 |
| Product quality issue | 1,269 | 7.3% | 0 | 17 |
| Application site pain | 1,217 | 7.0% | 0 | 3 |
| Migraine | 978 | 5.6% | 1 | 144 |
| Headache | 914 | 5.2% | 3 | 159 |
| Product complaint | 718 | 4.1% | 0 | 6 |
| Nausea | 702 | 4.0% | 0 | 93 |
| Product dose omission issue | 698 | 4.0% | 0 | 5 |
| Application site discolouration | 684 | 3.9% | 0 | 2 |
| Application site pruritus | 675 | 3.9% | 0 | 2 |
| Application site burn | 629 | 3.6% | 0 | 1 |
| Drug hypersensitivity | 628 | 3.6% | 0 | 19 |
Other Indications for SUMATRIPTAN
Migraine (8,854)
Product used for unknown indication (4,085)
Headache (1,020)
Cluster headache (302)
Migraine with aura (114)
Migraine without aura (92)
Ill-defined disorder (73)
Pain (48)
Migraine prophylaxis (39)
Adverse drug reaction (28)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)